Yibo Fan

2.6k total citations
75 papers, 1.6k citations indexed

About

Yibo Fan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yibo Fan has authored 75 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 31 papers in Oncology and 19 papers in Cancer Research. Recurrent topics in Yibo Fan's work include Cancer Immunotherapy and Biomarkers (10 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (7 papers). Yibo Fan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (7 papers). Yibo Fan collaborates with scholars based in China, United States and Australia. Yibo Fan's co-authors include Xiujuan Qu, Xiaofang Che, Kezuo Hou, Ce Li, Yunpeng Liu, Ti Wen, Zhi Li, Ling Xu, Shuo Wang and Yunpeng Liu and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Yibo Fan

72 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yibo Fan China 23 935 629 507 423 241 75 1.6k
Chenghai Zhao China 25 1.1k 1.1× 541 0.9× 437 0.9× 405 1.0× 197 0.8× 61 1.8k
Mariko Asaoka Japan 25 799 0.9× 778 1.2× 513 1.0× 351 0.8× 402 1.7× 64 1.8k
Jianjie Zhu China 25 1.1k 1.1× 864 1.4× 713 1.4× 526 1.2× 437 1.8× 63 2.1k
Dongdong Shi China 17 785 0.8× 685 1.1× 569 1.1× 575 1.4× 232 1.0× 30 1.7k
Ming Tang China 21 965 1.0× 352 0.6× 318 0.6× 302 0.7× 187 0.8× 63 1.8k
Shixiang Wang China 22 638 0.7× 586 0.9× 375 0.7× 381 0.9× 335 1.4× 59 1.6k
Simona Ruggieri Italy 20 782 0.8× 442 0.7× 317 0.6× 310 0.7× 170 0.7× 51 1.5k
Thomas Winder United States 20 924 1.0× 903 1.4× 362 0.7× 354 0.8× 212 0.9× 35 2.0k
Jiajie Hou China 18 679 0.7× 497 0.8× 369 0.7× 492 1.2× 125 0.5× 32 1.5k
Kun Mu China 23 949 1.0× 419 0.7× 310 0.6× 293 0.7× 222 0.9× 59 1.6k

Countries citing papers authored by Yibo Fan

Since Specialization
Citations

This map shows the geographic impact of Yibo Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yibo Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yibo Fan more than expected).

Fields of papers citing papers by Yibo Fan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yibo Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yibo Fan. The network helps show where Yibo Fan may publish in the future.

Co-authorship network of co-authors of Yibo Fan

This figure shows the co-authorship network connecting the top 25 collaborators of Yibo Fan. A scholar is included among the top collaborators of Yibo Fan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yibo Fan. Yibo Fan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Xin, Fernanda G. Kugeratski, Dara P. Dowlatshahi, et al.. (2025). Engineered Immunomodulatory Extracellular Vesicles from Epithelial Cells with the Capacity for Stimulation of Innate and Adaptive Immunity in Cancer and Autoimmunity. ACS Nano. 19(5). 5193–5216. 3 indexed citations
2.
3.
Yamashita, Kohei, Matheus Sewastjanow‐Silva, Katsuhiro Yoshimura, et al.. (2024). SMARCA4 Mutations in Gastroesophageal Adenocarcinoma: An Observational Study via a Next-Generation Sequencing Panel. Cancers. 16(7). 1300–1300. 1 indexed citations
4.
Sewastjanow‐Silva, Matheus, Kohei Yamashita, Ahmed Abdelhakeem, et al.. (2024). Three biomarkers ( HER2 , PD‐L1 , and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience. International Journal of Cancer. 155(12). 2277–2286. 2 indexed citations
5.
Yoshimura, Katsuhiro, Gengyi Zou, Yibo Fan, et al.. (2024). HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway inhibition in gastric cancer. Cancer Letters. 610. 217354–217354. 6 indexed citations
6.
Fan, Yibo, Shumei Song, Yuan Li, et al.. (2023). Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases. Cancer Research. 83(22). 3726–3738. 22 indexed citations
7.
Liu, Chang, Zhi Li, Lu Xu, et al.. (2020). GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M. Aging. 12(12). 11794–11811. 30 indexed citations
8.
Zhao, Huan, Chunlei Zheng, Yizhe Wang, et al.. (2020). miR-1323 Promotes Cell Migration in Lung Adenocarcinoma by Targeting Cbl-b and Is an Early Prognostic Biomarker. Frontiers in Oncology. 10. 181–181. 19 indexed citations
9.
Qi, Haiyan, Xiujuan Qu, Jing Liu, et al.. (2018). Bufalin induces protective autophagy by Cbl‐b regulating mTOR and ERK signaling pathways in gastric cancer cells. Cell Biology International. 43(1). 33–43. 29 indexed citations
10.
Yang, Zichang, Xiaonan Shi, Ce Li, et al.. (2018). Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis. Experimental Cell Research. 368(2). 194–201. 50 indexed citations
11.
Ma, Rui, Ling Xu, Xiujuan Qu, et al.. (2018). AZ304, a novel dual BRAF inhibitor, exerts anti-tumour effects in colorectal cancer independently of BRAF genetic status. British Journal of Cancer. 118(11). 1453–1463. 12 indexed citations
12.
Xu, Ling, Xiujuan Qu, Xuejun Hu, et al.. (2018). β‐elemene increases the sensitivity of gastric cancer cells to TRAIL by promoting the formation of DISC in lipid rafts. Cell Biology International. 42(10). 1377–1385. 19 indexed citations
13.
Wen, Ti, Zhenning Wang, Yi Li, et al.. (2017). A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer. Cancer Immunology Research. 5(7). 524–534. 46 indexed citations
14.
Zhang, Ye, Xiujuan Qu, Xiaofang Che, et al.. (2017). miR‐200a enhances TRAIL‐induced apoptosis in gastric cancer cells by targeting A20. Cell Biology International. 42(5). 506–514. 24 indexed citations
15.
Fan, Yibo, et al.. (2015). Effects of forkhead box C2 on carcinogenesis and lymphatic metastasis in endometrial carcinoma. Genetics and Molecular Research. 14(2). 5535–5547. 1 indexed citations
16.
Fan, Yibo, et al.. (2014). Cbl-b accelerates trypsin-induced cell detachment through ubiquitination and degradation of proline-rich tyrosine kinase 2. Tumor Biology. 35(11). 11129–11135. 6 indexed citations
17.
Zhang, Ye, Xiujuan Qu, Ce Li, et al.. (2014). miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1. Tumor Biology. 36(4). 2277–2285. 58 indexed citations
18.
Qu, Xiujuan, Yibo Fan, Xiaofang Che, et al.. (2013). Trastuzumab and oxaliplatin exhibit a synergistic antitumor effect in HER2-postive gastric cancer cells. Anti-Cancer Drugs. 25(3). 315–322. 12 indexed citations
20.
Preti, Robert A., et al.. (1994). The Combined Use of Soybean Agglutinin and Immunomagnetic Beads for T Lymphocyte Subset Depletion of Bone Marrow Allografts: A Laboratory Analysis. Journal of Hematotherapy. 3(2). 111–120. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026